688426 康为世纪
已收盘 10-09 15:00:00
资讯
新帖
简况
康为世纪（688426）10月8日主力资金净卖出8.16万元
证券之星 · 10-09 08:33
康为世纪（688426）10月8日主力资金净卖出8.16万元
股市必读：康为世纪新发布《关于董事会秘书取得任职培训证明并正式履职的公告》
证券之星 · 09-30
股市必读：康为世纪新发布《关于董事会秘书取得任职培训证明并正式履职的公告》
康为世纪（688426）披露董事会秘书正式履职公告，9月28日股价下跌3.23%
证券之星 · 09-28
康为世纪（688426）披露董事会秘书正式履职公告，9月28日股价下跌3.23%
康为世纪生物科技（688426）9月24日主力资金净卖出318.91万元
证券之星 · 09-25
康为世纪生物科技（688426）9月24日主力资金净卖出318.91万元
康为世纪生物科技（688426）9月23日主力资金净买入815.00万元
证券之星 · 09-24
康为世纪生物科技（688426）9月23日主力资金净买入815.00万元
康为世纪(688426.SH)向122名激励对象授予310万股限制性股票
智通财经 · 09-17
康为世纪(688426.SH)向122名激励对象授予310万股限制性股票
股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》
证券之星 · 09-14
股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》
每周股票复盘：康为世纪（688426）推2026年限制性股票激励计划
证券之星 · 09-13
每周股票复盘：康为世纪（688426）推2026年限制性股票激励计划
股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》
证券之星 · 09-11
股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》
康为世纪（688426）披露2026年限制性股票激励计划草案，9月10日股价下跌2.14%
证券之星 · 09-10
康为世纪（688426）披露2026年限制性股票激励计划草案，9月10日股价下跌2.14%
每周股票复盘：康为世纪（688426）董事会人事变动及激励计划进展
证券之星 · 09-06
每周股票复盘：康为世纪（688426）董事会人事变动及激励计划进展
股市必读：康为世纪新发布《关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-03
股市必读：康为世纪新发布《关于召开2026年半年度业绩说明会的公告》
股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》
证券之星 · 09-02
股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》
股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》
证券之星 · 09-01
股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》
康为世纪（688426）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月31日股价上涨1.2%
证券之星 · 08-31
康为世纪（688426）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月31日股价上涨1.2%
康为世纪（688426）披露2026年半年度报告，8月27日股价下跌2.18%
证券之星 · 08-27
康为世纪（688426）披露2026年半年度报告，8月27日股价下跌2.18%
图解康为世纪中报：第二季度单季净利润同比增长40.20%
证券之星 · 08-27
图解康为世纪中报：第二季度单季净利润同比增长40.20%
康为世纪(688426.SH)发布半年度业绩，归母净亏损3518万元
智通财经 · 08-27
康为世纪(688426.SH)发布半年度业绩，归母净亏损3518万元
每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证
证券之星 · 08-23
每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证
康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%
证券之星 · 08-20
康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%
加载更多
公司概况
公司名称：
江苏康为世纪生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2022-10-25
主营业务：
江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂、创新型分子诊断试剂盒、微生物绝对定量、癌症早筛、遗传病检测、抗衰老检测、全质粒测序。
发行价格：
48.98
{"stockData":{"symbol":"688426","market":"SH","secType":"STK","nameCN":"康为世纪","latestPrice":21.51,"timestamp":1791529200000,"preClose":21.36,"halted":0,"volume":2478743,"delay":0,"changeRate":0.007,"floatShares":112000000,"shares":112000000,"eps":-0.7706,"marketStatus":"已收盘","change":0.15,"latestTime":"10-09 15:00:00","open":21.26,"high":21.64,"low":20.43,"amount":51999500,"amplitude":0.0566,"askPrice":21.52,"askSize":0,"bidPrice":21.51,"bidSize":14,"shortable":0,"etf":0,"ttmEps":-0.7706,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"adjPreClose":21.36,"symbolType":"stock_kcb","openAndCloseTimeList":[[1791509400000,1791516600000],[1791522000000,1791529200000]],"highLimit":23.5,"lowLimit":19.22,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112493716,"isCdr":false,"pbRate":1.84,"roa":"--","roe":"--","epsLYR":-0.977,"committee":-0.480315,"marketValue":2420000000,"turnoverRate":0.0221,"status":0,"afterMarket":{"amount":0,"volume":0,"close":21.51,"buyVolume":0,"sellVolume":0,"time":1791531237746,"indexStatus":"已收盘 10-09 15:30:00","preClose":21.36},"floatMarketCap":2414000000},"requestUrl":"/m/hq/s/688426","defaultTab":"news","newsList":[{"id":"2674889667","title":"康为世纪（688426）10月8日主力资金净卖出8.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674889667","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674889667?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:33","pubTimestamp":1791506018,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，康为世纪报收于21.36元，下跌5.4%，换手率3.15%，成交量3.54万手，成交额7736.15万元。近5日资金流向一览见下表：康为世纪融资融券信息显示，融资方面，当日融资买入781.76万元，融资偿还585.85万元，融资净买入195.91万元。康为世纪主营业务：分子检测底层核心技术的自主研发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900006250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671410452","title":"股市必读：康为世纪新发布《关于董事会秘书取得任职培训证明并正式履职的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671410452","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671410452?lang=zh_cn&edition=full","pubTime":"2026-09-30 02:29","pubTimestamp":1790706549,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，康为世纪报收于21.23元，下跌0.09%，换手率3.02%，成交量3.38万手，成交额7194.97万元。当日关注点交易信息汇总：9月29日主力资金净流出169.65万元，占总成交额2.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670588255","title":"康为世纪（688426）披露董事会秘书正式履职公告，9月28日股价下跌3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670588255","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670588255?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:28","pubTimestamp":1790605705,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，康为世纪报收于21.25元，较前一交易日下跌3.23%，最新总市值为23.9亿元。该股当日开盘21.87元，最高22.83元，最低21.0元，成交额达8631.89万元，换手率为3.55%。近日，康为世纪发布《关于董事会秘书取得任职培训证明并正式履职的公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670419992","title":"康为世纪生物科技（688426）9月24日主力资金净卖出318.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670419992","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670419992?lang=zh_cn&edition=full","pubTime":"2026-09-25 08:22","pubTimestamp":1790295736,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月24日收盘，康为世纪生物科技报收于21.96元，下跌7.69%，换手率3.76%，成交量4.22万手，成交额9528.14万元。近5日资金流向一览见下表：康为世纪生物科技融资融券信息显示，融资方面，当日融资买入860.48万元，融资偿还626.98万元，融资净买入233.5万元。康为世纪生物科技主营业务：分子检测底层核心技术的自主研发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092500005072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","HBImain","159837","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432756","title":"康为世纪生物科技（688426）9月23日主力资金净买入815.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432756","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669432756?lang=zh_cn&edition=full","pubTime":"2026-09-24 08:14","pubTimestamp":1790208843,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，康为世纪生物科技报收于23.79元，上涨7.99%，换手率5.25%，成交量5.9万手，成交额1.41亿元。近5日资金流向一览见下表：康为世纪生物科技融资融券信息显示，融资方面，当日融资买入1293.17万元，融资偿还803.94万元，融资净买入489.23万元。康为世纪生物科技主营业务：分子检测底层核心技术的自主研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400007634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HBImain","BK0239","688426","159837"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668080968","title":"康为世纪(688426.SH)向122名激励对象授予310万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2668080968","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2668080968?lang=zh_cn&edition=full","pubTime":"2026-09-17 17:25","pubTimestamp":1789637113,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪(688426.SH)发布公告，公司于2026年9月17日召开的第二届董事会第二十六次会议《关于向2026年限制性股票激励计划激励对象首次授予限制性股票的议案》，确定2026年9月17日为首次授予日，以11.22元/股的授予价格向符合授予条件的122名激励对象授予310万股限制性股票。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1497417.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667863820","title":"股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667863820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667863820?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:08","pubTimestamp":1789330094,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，康为世纪报收于20.37元，下跌1.02%，换手率1.29%，成交量1.45万手，成交额2974.97万元。上海市通力律师事务所关于江苏康为世纪生物科技股份有限公司2026年第三次临时股东会的法律意见书上海市通力律师事务所就康为世纪2026年第三次临时股东会出具法律意见书，确认会议由董事会召集，采取现场与网络投票相结合方式召开；审议通过上述三项议案；表决结果合法有效，出席人员资格及召集人资格符合规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001798.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667450021","title":"每周股票复盘：康为世纪（688426）推2026年限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2667450021","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667450021?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:49","pubTimestamp":1789242549,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，康为世纪报收于20.37元，较上周的21.0元下跌3.0%。本周，康为世纪9月9日盘中最高价报21.79元。本周关注点公司公告汇总：康为世纪召开2026年第三次临时股东会，审议通过2026年限制性股票激励计划相关议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666196518","title":"股市必读：康为世纪新发布《2026年第三次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666196518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666196518?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:13","pubTimestamp":1789067590,"startTime":"0","endTime":"0","summary":"公司公告汇总：康为世纪于2026年9月10日召开第三次临时股东会，审议通过2026年限制性股票激励计划相关三项议案，均获出席会议股东所持表决权2/3以上通过。上海市通力律师事务所关于江苏康为世纪生物科技股份有限公司2026年第三次临时股东会的法律意见书上海市通力律师事务所就江苏康为世纪生物科技股份有限公司2026年第三次临时股东会出具法律意见书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100003102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666550594","title":"康为世纪（688426）披露2026年限制性股票激励计划草案，9月10日股价下跌2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666550594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666550594?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:47","pubTimestamp":1789051631,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，康为世纪报收于20.58元，较前一交易日下跌2.14%，最新总市值为23.15亿元。该股当日开盘20.95元，最高21.21元，最低20.51元，成交额达1757.87万元，换手率为0.75%。三项议案均为特别决议议案，已获出席会议股东所持表决权的2/3以上通过。激励对象及其关联方未参与表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366666","title":"每周股票复盘：康为世纪（688426）董事会人事变动及激励计划进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366666","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366666?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:36","pubTimestamp":1788636972,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，康为世纪报收于21.0元，较上周的20.77元上涨1.11%。本周，康为世纪9月2日盘中最高价报21.82元。公司公告汇总：2026年限制性股票激励计划激励对象名单公示期无异议，符合规定条件。公司于2026年8月21日至8月31日对2026年限制性股票激励计划拟激励对象的姓名和职务进行了内部公示，公示期间未收到异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664846897","title":"股市必读：康为世纪新发布《关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664846897","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664846897?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:39","pubTimestamp":1788374350,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，康为世纪报收于21.47元，上涨0.99%，换手率1.89%，成交量2.12万手，成交额4558.78万元。公司公告汇总：康为世纪将于9月9日16:00-17:00通过上证路演中心召开2026年半年度业绩说明会，董事长兼总经理王春香博士、董事会秘书谢俊先生将出席。投资者可于2026年9月3日至9月8日中午12:00前通过上证路演中心网站或公司邮箱IRM@cwbio.cn提交问题。说明会后可通过该平台查看会议内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664865669","title":"股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664865669","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664865669?lang=zh_cn&edition=full","pubTime":"2026-09-02 02:31","pubTimestamp":1788287469,"startTime":"0","endTime":"0","summary":"关于聘任公司内部审计负责人的公告江苏康为世纪生物科技股份有限公司于2026年8月31日召开第二届董事会第二十五次会议，审议通过聘任李斌先生为公司内部审计负责人，任期自董事会审议通过之日起至第二届董事会届满为止。董事会薪酬与考核委员会关于公司2026年限制性股票激励计划授予激励对象名单的核查意见及公示情况说明公司于2026年8月20日召开第二届董事会第二十四次会议，审议通过《2026年限制性股票激励计划（草案）》及其摘要。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200002430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664008990","title":"股市必读：康为世纪新发布《第二届董事会第二十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664008990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664008990?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:12","pubTimestamp":1788199934,"startTime":"0","endTime":"0","summary":"公司公告汇总第二届董事会第二十五次会议决议公告江苏康为世纪生物科技股份有限公司于2026年8月31日召开第二届董事会第二十五次会议，审议通过《关于聘任董事会秘书的议案》和《关于聘任公司内部审计负责人的议案》，同意聘任谢俊为董事会秘书、李斌为内部审计负责人，任期均至第二届董事会届满；两人均未持有公司股票，与主要股东及高管无关联关系；原董事会秘书戚玉柏已于2026年8月28日辞去职务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663039074","title":"康为世纪（688426）披露2026年限制性股票激励计划内幕信息知情人买卖公司股票自查报告，8月31日股价上涨1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663039074","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663039074?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:29","pubTimestamp":1788172163,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，康为世纪报收于21.02元，较前一交易日上涨1.2%，最新总市值为23.65亿元。该股当日开盘20.46元，最高21.43元，最低20.35元，成交额达4817.32万元，换手率为2.04%。公司于近日披露《关于2026年限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告》。公告显示，江苏康为世纪生物科技股份有限公司于2026年8月20日召开第二届董事会第二十四次会议，审议通过《2026年限制性股票激励计划（草案）》及其摘要，并于8月21日披露相关公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100028334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662701104","title":"康为世纪（688426）披露2026年半年度报告，8月27日股价下跌2.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701104","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662701104?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:27","pubTimestamp":1787830032,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，康为世纪报收于21.11元，较前一交易日下跌2.18%，最新总市值为23.75亿元。该股当日开盘21.33元，最高21.65元，最低21.0元，成交额达3514.08万元，换手率为1.48%。近日，江苏康为世纪生物科技股份有限公司召开第二届董事会第二十三次会议，审议通过《2026年半年度报告》及其摘要、《2026年半年度募集资金存放、管理与实际使用情况的专项报告》及《2026年度提质增效重回报专项行动方案的半年度评估报告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662370936","title":"图解康为世纪中报：第二季度单季净利润同比增长40.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662370936","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662370936?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:58","pubTimestamp":1787828296,"startTime":"0","endTime":"0","summary":"证券之星消息，康为世纪2026年中报显示，上半年度公司主营收入1.13亿元，同比上升29.73%；归母净利润-3518.49万元，同比上升37.07%；扣非净利润-4538.54万元，同比上升31.81%；其中2026年第二季度，公司单季度主营收入5402.25万元，同比上升22.46%；单季度归母净利润-1983.28万元，同比上升40.2%；单季度扣非净利润-2480.44万元，同比上升34.36%；负债率10.83%，投资收益299.86万元，财务费用121.34万元，毛利率48.81%。财报数据概要请见下图:本文数据来源于康为世纪2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720687","title":"康为世纪(688426.SH)发布半年度业绩，归母净亏损3518万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720687","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662720687?lang=zh_cn&edition=full","pubTime":"2026-08-27 17:13","pubTimestamp":1787822023,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪(688426.SH)披露2026年半年度报告，报告期公司实现营业收入1.13亿元，同比增长29.73%;归属于上市公司股东的净利润亏损3518万元，同比收窄;归属于上市公司股东的扣除非经常性损益的净利润亏损4539万元，同比收窄;基本每股收益-0.320元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"康为世纪(688426.SH)发布半年度业绩，归母净亏损3518万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661114312","title":"每周股票复盘：康为世纪（688426）获肺炎支原体检测试剂三类证","url":"https://stock-news.laohu8.com/highlight/detail?id=2661114312","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661114312?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:18","pubTimestamp":1787422692,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，康为世纪报收于22.42元，较上周的19.12元上涨17.26%。本周，康为世纪8月21日盘中最高价报23.39元。本周关注点公司公告汇总：肺炎支原体核酸及耐药突变位点检测试剂盒获Ⅲ类医疗器械注册证。本次获批进一步丰富了公司呼吸道病原体检测试剂产品管线，对公司未来经营发展具有积极影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428002","title":"康为世纪（688426）披露2026年限制性股票激励计划草案，8月20日股价上涨19.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428002","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660428002?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:12","pubTimestamp":1787235139,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，康为世纪报收于22.87元，较前一交易日上涨19.99%，最新总市值为25.73亿元。该股当日开盘20.5元，最高22.87元，最低20.09元，成交额达4776.78万元，换手率为1.9%。近日，康为世纪发布《关于召开2026年第三次临时股东会的通知》，拟于2026年9月10日召开2026年第三次临时股东会，审议《2026年限制性股票激励计划（草案）》及其摘要、实施考核管理办法、授权董事会办理相关事宜等三项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791583258415,"stockEarnings":[{"period":"1week","weight":-0.0474},{"period":"1month","weight":0.0228},{"period":"3month","weight":0.2564},{"period":"6month","weight":0.067},{"period":"1year","weight":-0.2301},{"period":"ytd","weight":-0.0974}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.0433},{"period":"1year","weight":-0.0305},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏康为世纪生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4610人(较上一季度增加4.63%)","perCapita":"24344股","listingDate":"2022-10-25","address":"江苏省泰州市海陵区医药高新区泽兰路18号","registeredCapital":"11249万元","survey":" 江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂、创新型分子诊断试剂盒、微生物绝对定量、癌症早筛、遗传病检测、抗衰老检测、全质粒测序。","listedPrice":48.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康为世纪,688426,康为世纪股票,康为世纪股票老虎,康为世纪股票老虎国际,康为世纪行情,康为世纪股票行情,康为世纪股价,康为世纪股市,康为世纪股票价格,康为世纪股票交易,康为世纪股票购买,康为世纪股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}